PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $56,000 | -91.9% | 2,430 | -96.4% | 0.00% | – |
| Q3 2020 | $694,000 | -36.1% | 68,161 | -6.5% | 0.00% | – |
| Q2 2020 | $1,086,000 | +19.6% | 72,888 | -2.2% | 0.00% | – |
| Q1 2020 | $908,000 | -25.3% | 74,540 | -2.9% | 0.00% | – |
| Q4 2019 | $1,215,000 | +27.6% | 76,764 | -1.0% | 0.00% | – |
| Q3 2019 | $952,000 | +589.9% | 77,559 | +639.7% | 0.00% | – |
| Q2 2019 | $138,000 | – | 10,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|